ELVN · Enliven Therapeutics, Inc.
Market Cap
$4.24B
Shares
73.27M
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-08-11 | 1,426 | $59.42 | $84,733 |
| 2026-07-30 | 8 | $52.97 | $424 |
| 2026-07-27 | 990 | $52.95 | $52,421 |
| 2026-07-24 | 200 | $52.81 | $10,562 |
| 2026-07-23 | 200 | $52.85 | $10,570 |
| 2026-07-22 | 200 | $54.33 | $10,866 |
| 2026-07-15 | 44 | $51.73 | $2,276 |
| 2026-07-14 | 402 | $50.87 | $20,450 |
| 2026-07-10 | 8 | $52.18 | $417 |
| 2026-07-02 | 89 | $48.76 | $4,340 |
| 2026-07-01 | 11 | $50.75 | $558 |
| 2026-06-30 | 39,831 | $50.85 | $2,025,406 |
| 2026-06-18 | 146 | $44.86 | $6,550 |
| 2026-06-09 | 33,071 | $33.63 | $1,112,178 |
| 2026-06-05 | 31,591 | $35.49 | $1,121,165 |
| 2026-06-04 | 6,633 | $36.03 | $238,987 |
| 2026-06-02 | 14 | $37.51 | $525 |
Showing 1–17 of 17 settlements
Key facts
CIK
1672619
CUSIP
29337E102
13F (30d)
196 filings
193 filers
Visit website
Investor relations